{ "ok": true, "cik": "1854183", "ticker": "ORIB", "name": "ORION BLISS CORP.", "filings": [ { "form": "10-Q", "filed": "2026-08-25", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826006716/0001683168-26-006716-index.htm" }, { "form": "10-K", "filed": "2026-07-08", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826005342/0001683168-26-005342-index.htm" }, { "form": "10-Q", "filed": "2026-02-17", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826001111/0001683168-26-001111-index.htm" }, { "form": "8-K", "filed": "2026-01-21", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826000443/0001683168-26-000443-index.htm" }, { "form": "10-Q", "filed": "2025-11-26", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316825008685/0001683168-25-008685-index.htm" }, { "form": "8-K", "filed": "2025-11-12", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316825008183/0001683168-25-008183-index.htm" } ], "events12m": 2, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 2, "latest": { "filed": "2026-01-21", "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826000443/0001683168-26-000443-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001854183.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1854183" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up ORION BLISS CORP. ($ORIB). Last filing: 10-Q, 2026-08-25. 2 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2026-04-30", "revenue": 12000, "revenueGrowth1y": -0.5387276571208918, "revenueGrowthPerYear": null, "yearsOfData": 5, "operatingMargin": -3.4105, "operatingMarginPrior": -0.5651739381126273, "netMargin": -3.4105, "operatingCashFlow": -31826, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 0, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2022-04-30", "revenue": 0 }, { "fiscalYearEnd": "2023-04-30", "revenue": 600 }, { "fiscalYearEnd": "2024-04-30", "revenue": 500 }, { "fiscalYearEnd": "2025-04-30", "revenue": 26015 }, { "fiscalYearEnd": "2026-04-30", "revenue": 12000 } ], "totalEquity": -144822, "totalAssets": 37025, "equityRatio": -3.9114652261985143, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 0, "sharesOutstanding": 3038000, "bookValuePerShare": -0.04767017774851876, "revenuePerShare": 0.003949967083607637, "range80": { "low": 9761.511320238973, "high": 35911.31340064988, "baseline": 19054.139756844088, "n": 2483, "band": "b000", "bandLabel": "under $50M", "method": "v4.1", "credibility": 0.25, "growthYears": 2, "ownVolatility": 0.41821483253763203, "classVolatility": 0.3000583276631395, "volatility": 0.3335448418708044 }, "ifPaceHeld": { "low": 9761.511320238973, "high": 35911.31340064988 } }, "edgarette": "🔖 Exposure: revenue $12K (FY2026). Experience: revenue down 53.9% on the year; operating margin -341.1%, down from -56.5%. Soundness: equity -391.1% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $10K and $36K next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $9K to $39K. A statistical range, not company guidance. Against peers (14 filers, $50M+ revenue, its industry group): operating margin -341.1% against a 4.2% median; growth -53.9% against 0.8%.", "peers": { "sic": 2840, "sicDescription": "Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "284", "growth": [ 0.0084, 14 ], "opMargin": [ 0.0422, 14 ], "equityRatio": [ 0.395, 14 ], "returnOnEquity": [ 0.0377, 11 ] }, "summary": "Orion Bliss (ORIB) saw revenue fall 53.9% in FY2026 to $0 million, operating margin -341% against a 4.2% median for soap, detergents, cleang preparations, perfumes, cosmetics, equity -391% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
ORION BLISS CORP. against its own record and its peers
Operating marginPeer median 4.2%-341.1%Revenue, on the yearPeer median 0.8%-53.9%Equity of assetsPeer median 39.5%-391.1%Gold tick: the median of 14–14 peers with $50M+ revenue in soap, detergents, cleang preparations, perfumes, cosmetics
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v4", "byYear": {}, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-27T23:01:06.797Z", "hash": "f20f4edde67be1e4", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Orion Bliss (ORIB) saw revenue fall 53.9% in FY2026 to $0 million, operating margin -341% against a 4.2% median for soap, detergents, cleang preparations, perfumes, cosmetics, equity -391% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2026-04-30", "revenue": 12000, "totalDebt": null, "cash": 0 }, "experience": { "revenueGrowth1y": -0.5387276571208918, "revenueGrowthPerYear": null, "operatingMargin": -3.4105, "operatingMarginPrior": -0.5651739381126273, "netMargin": -3.4105, "freeCashFlow": null }, "soundness": { "equityRatio": -3.9114652261985143, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2840, "sicDescription": "Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "284", "growth": [ 0.0084, 14 ], "opMargin": [ 0.0422, 14 ], "equityRatio": [ 0.395, 14 ], "returnOnEquity": [ 0.0377, 11 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 2, "latest": { "filed": "2026-01-21", "url": "https://www.sec.gov/Archives/edgar/data/1854183/000168316826000443/0001683168-26-000443-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 9761.511320238973, "high": 35911.31340064988, "baseline": 19054.139756844088, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 2483, "sizeBand": "under $50M", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.25, "growthYears": 2, "ownVolatility": 0.41821483253763203, "classVolatility": 0.3000583276631395, "pricedVolatility": 0.3335448418708044, "k": 3 }, "stress": { "low": 8927.355304080065, "high": 39388.90570333341, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v4", "byYear": {}, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-27T23:01:06.797Z", "hash": "f20f4edde67be1e4", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001854183.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1854183" }, "speedCash": null, "harbor": { "signs": [ { "key": "range", "text": "revenue is hard to predict: its 80% range is ±57%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2026-04-30", "operating": -31826, "investing": 0, "financing": 17347, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2022-04-30", "operating": -26824, "free": null }, { "fiscalYearEnd": "2023-04-30", "operating": -29182, "free": null }, { "fiscalYearEnd": "2024-04-30", "operating": -52356, "free": null }, { "fiscalYearEnd": "2025-04-30", "operating": -10153, "free": null }, { "fiscalYearEnd": "2026-04-30", "operating": -31826, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2026-04-30", "cash": 0, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 37025, "ladder": null, "currentRatio": 0.03, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "range", "text": "revenue is hard to predict: its 80% range is ±57%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2026-04-30", "operating": -31826, "investing": 0, "financing": 17347, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2022-04-30", "operating": -26824, "free": null }, { "fiscalYearEnd": "2023-04-30", "operating": -29182, "free": null }, { "fiscalYearEnd": "2024-04-30", "operating": -52356, "free": null }, { "fiscalYearEnd": "2025-04-30", "operating": -10153, "free": null }, { "fiscalYearEnd": "2026-04-30", "operating": -31826, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2026-04-30", "cash": 0, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 37025, "ladder": null, "currentRatio": 0.03, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }